Simvastatin treatment prolongs the survival of scrapie-infected mice

NeuroReport

Volumn 18, Issue 5, 2007, Pages 479-482

  Kempster, Sarah ^a   Bate, Clive ^b   Williams, Alun ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Behaviour; Cholesterol; Prions; Statins

Indexed keywords

SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENERAL CONDITION DETERIORATION; HYPERCHOLESTEROLEMIA; MOTOR PERFORMANCE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PRION DISEASES; SIMVASTATIN; SURVIVAL RATE;

EID: 34247589262     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328058678d     Document Type: Article

References (13)

1. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-13383.
2. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993; 90:10962-10966.
3. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl- coenzyme. A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A 1980; 77:3957-3961.
4. Locatelli S, Lutjohann D, Schmidt HH, Otto C, Beisiegel U, Von Bergmann K. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol 2002; 59:213-216.
5. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB, et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121-132.
6. Bate C, Salmona M, Diomede L, Williams A. Squalestatin cures prioninfected neurones and protects against prion neurotoxicity. J Biol Chem 2004; 279:14983-14990.
7. Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res 1994; 11:305-311.
8. Hess DC, Fagan SC. Pharmacology and clinical experience with simvastatin. Expert Opin Pharmacother 2001; 2:153-163.
9. Kempster S, Collins ME, Deacon R, Edington N. Impaired motor coordination on static rods in BSE-infected mice. Behav Brain Res 2004; 154:291-295.
10. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A 1996; 93:14945-14949.
11. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1:31-39.
12. Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 2000; 26:41-54.
13. Pfrieger FW. Role of cholesterol in synapse formation and function. BBA Biomembranes 2003; 1610:271-280.